On March 23, 2011, Merck filed a petition with the U.S. Judicial Panel on Multidistrict Litigation to consolidate 36 Fosamax femur fracture lawsuits that the drug manufacturer is currently defending in federal courts nationwide. Plaintiffs in these lawsuits allege that their long-term use of Fosamax caused them to sustain femur fractures. The lawyers at Bernstein Liebhard LLP are currently investigating cases on behalf of our clients who have suffered femur fractures after long term bisphosphonate use and are offering free and confidential legal consultations to individuals who took Fosamax or other bone drugs and fractured their femoral bone.

Recently, Fosamax and similar medications have been the subject of increased scrutiny as numerous studies release findings which substantiate a link between Fosamax use and atypical femur fractures. In October 2010, the U.S. Food and Drug Administration (“FDA”) issued a warning that Fosamax and other bisphosphonates put patients at risk for atypical thigh bone (femur) fractures. In addition to issuing that warning, the FDA required that bisphosphonate manufacturers, such as Merck, change the drugs’ labeling.

Fosamax MDL for Femur Fractures

If the U.S. Judicial Panel on Multidistrict Litigation grants Merck’s request, all of the federal Fosamax femur fracture lawsuits will be consolidated and centralized before a single judge for pretrial purposes. If the panel agrees to form a femur fracture MDL defendants have asked that the cases be consolidated before Judge Garrett Brown in the U.S. District Court for the District of New Jersey.

Bernstein Liebhard LLP is actively investigating cases on behalf of clients who have suffered a Fosamax femur fracture. In 2008, the FDA issued its first warning regarding the dangers associated with Fosamax use. Since that time, Bernstein Liebhard LLP has provided a wealth of consumer information concerning the risks associated with Fosamax use on its website, If you or a loved one took Fosamax and sustained a femur fracture, you may be entitled to compensation for medical bills, pain and suffering, lost wages and other injuries.

For more information about filing a Fosamax femur fracture lawsuit, contact an attorney at Bernstein Liebhard LLP at (877) 779-1414 or at

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2010 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Felecia L. Stern, Esq.
(877) 779-1414

Published March 30, 2011 by